Reckitt Investors Sue On Suboxone Fraud, $1.4 Billion Settlement

Reckitt Benckiser Group PLC didn’t tell investors its marketing on an opioid addiction treatment drug’s supposed safety wasn’t accurate, a July 15 suit said.

The household and health products manufacturer falsely marketed Suboxone Film as safer to use around children than a tablet form with generic alternatives, despite evidence it posed more risks, the complaint filed in the U.S. District Court for the District of New Jersey said.

Reckitt agreed July 11 to pay $1.4 billion in forfeiture and fines to end Justice Department and Federal Trade Commission probes into its Suboxone marketing practices. The company’s share price fell 5% ...